Preemptive Therapy Prevents Cytomegalovirus End-Organ Disease in Treatment-Naïve Patients with Advanced HIV-1 Infection in the HAART Era

• Daisuke Mizushima,

  Affiliations AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan, Center for AIDS Research, Kumamoto University, Kumamoto, Japan

  ⨯
• Takeshi Nishijima,

  Affiliations AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan, Center for AIDS Research, Kumamoto University, Kumamoto, Japan

  ⨯
• Hiroyuki Gatanaga ,

  * E-mail: higatana@acc.ncgm.go.jp

  Affiliations AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan, Center for AIDS Research, Kumamoto University, Kumamoto, Japan

  ⨯
• Kunihisa Tsukada,

  Affiliation AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan

  ⨯
• Katsuji Teruya,

  Affiliation AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan

  ⨯
• Yoshimi Kikuchi,

  Affiliation AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan

  ⨯
• Shinichi Oka

  Affiliations AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan, Center for AIDS Research, Kumamoto University, Kumamoto, Japan

  ⨯